GE HealthCare Technologies Inc. (GEHC) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $61.13 (+0.48%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 4, 2026 | Rick Wise | Stifel Nicolaus | $98.00 | +60.3% |
| Feb 4, 2026 | Ryan Zimmerman | BTIG | $91.00 | +48.9% |
| Nov 21, 2025 | Rick Wise | Stifel Nicolaus | $90.00 | +47.2% |
| Oct 30, 2025 | Larry Biegelsen | Wells Fargo | $87.00 | +42.3% |
| Oct 13, 2025 | Ryan Zimmerman | BTIG | $89.00 | +45.6% |
| May 5, 2025 | Graham Doyle | UBS | $73.00 | +19.4% |
| Apr 14, 2025 | Ryan Zimmerman | BTIG | $95.00 | +55.4% |
| Nov 15, 2024 | Jason Bednar | Piper Sandler | $97.00 | +58.7% |
| Sep 26, 2024 | Graham Doyle | UBS | $74.00 | +21.1% |
| Sep 20, 2024 | Craig Bijou | Bank of America Securities | $97.00 | +58.7% |
| Sep 18, 2024 | Ryan Zimmerman | BTIG | $100.00 | +63.6% |
| May 30, 2024 | David Roman | Goldman Sachs | $87.00 | +42.3% |
| May 21, 2024 | Jason Bednar | Piper Sandler | $92.00 | +50.5% |
| May 1, 2024 | Anthony Petrone | Mizuho Securities | $105.00 | +71.8% |
| Apr 30, 2024 | Vijay Kumar | Evercore ISI | $96.00 | +57.0% |
| Apr 11, 2024 | Anthony Petrone | Mizuho Securities | $110.00 | +79.9% |
| Apr 1, 2024 | David Toung | Argus Research | $110.00 | +79.9% |
| Feb 12, 2024 | Graham Doyle | UBS | $88.00 | +44.0% |
| Jun 27, 2023 | Patrick Wood | Morgan Stanley | $76.00 | +24.3% |
| May 16, 2023 | Suraj Kalia | Oppenheimer | $97.00 | +58.7% |
Top Analysts Covering GEHC
GEHC vs Sector & Market
| Metric | GEHC | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.41 | 2.24 | 2.41 |
| Analyst Count | 29 | 8 | 18 |
| Target Upside | +37.4% | +1150.2% | +14.9% |
| P/E Ratio | 18.69 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $5.21B | $5.26B | $5.32B | 9 |
| 2026-09-30 | $5.34B | $5.41B | $5.47B | 4 |
| 2026-12-31 | $21.24B | $21.71B | $21.99B | 14 |
| 2027-03-31 | $5.19B | $5.27B | $5.31B | 4 |
| 2027-06-30 | $5.41B | $5.50B | $5.54B | 4 |
| 2027-09-30 | $5.54B | $5.63B | $5.67B | 5 |
| 2027-12-31 | $6.22B | $6.32B | $6.37B | 4 |
| 2028-03-31 | $5.33B | $5.41B | $5.45B | 3 |
| 2028-06-30 | $5.61B | $5.70B | $5.75B | 3 |
| 2028-09-30 | $5.70B | $5.79B | $5.84B | 5 |
| 2028-12-31 | $6.44B | $6.54B | $6.59B | 3 |
| 2029-12-31 | $24.95B | $25.49B | $25.90B | 12 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $1.14 | $1.17 | $1.20 | 9 |
| 2026-09-30 | $1.23 | $1.25 | $1.27 | 3 |
| 2026-12-31 | $4.61 | $5.06 | $5.15 | 13 |
| 2027-03-31 | $1.16 | $1.19 | $1.20 | 3 |
| 2027-06-30 | $1.28 | $1.31 | $1.32 | 3 |
| 2027-09-30 | $1.38 | $1.41 | $1.42 | 4 |
| 2027-12-31 | $1.67 | $1.71 | $1.72 | 3 |
| 2028-03-31 | $1.24 | $1.27 | $1.28 | 4 |
| 2028-06-30 | $1.40 | $1.43 | $1.45 | 4 |
| 2028-09-30 | $1.49 | $1.52 | $1.53 | 6 |
| 2028-12-31 | $1.86 | $1.89 | $1.91 | 4 |
| 2029-12-31 | $6.92 | $7.11 | $7.26 | 6 |
Frequently Asked Questions
What is the analyst consensus for GEHC?
The consensus among 29 analysts covering GE HealthCare Technologies Inc. (GEHC) is Buy with an average price target of $91.70.
What is the highest price target for GEHC?
The highest price target for GEHC is $110.00, set by Anthony Petrone at Mizuho Securities on 2024-04-11.
What is the lowest price target for GEHC?
The lowest price target for GEHC is $73.00, set by Graham Doyle at UBS on 2025-05-05.
How many analysts cover GEHC?
29 analysts have issued ratings for GE HealthCare Technologies Inc. in the past 12 months.
Is GEHC a buy or sell right now?
Based on 29 analyst ratings, GEHC has a consensus rating of Buy (2.41/5) with a +37.4% upside to the consensus target of $91.70.
What are the earnings estimates for GEHC?
Analysts estimate GEHC will report EPS of $1.17 for the period ending 2026-06-30, with revenue estimated at $5.26B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.